SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS
申请人:Bayer AG
公开号:EP3800188A1
公开(公告)日:2021-04-07
The present application relates to novel pyrazolopyrimidine derivatives for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases in humans and in animals, especially of proliferative disorders, autoimmune disorders, metabolic and inflammatory disorders characterized by an overreacting immune system, in particular rheumatological disorders, inflammatory skin disorders, cardiovascular disorders, lung disorders, eye disorders, neurological disorders, pain disorders and cancer, in human as well as of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.
Palladium-Catalyzed Cross-Coupling of Aryl Chlorides and Tosylates with Hydrazine
作者:Rylan J. Lundgren、Mark Stradiotto
DOI:10.1002/anie.201003764
日期:2010.11.8
Hydrazine is not a problem anymore: The title transformation is the first reaction to yield aryl hydrazines through the cross‐coupling of aryl chlorides and tosylates with hydrazine. An appropriately designed palladium catalyst allows this reaction to proceed rapidly under mild conditions, and with excellent chemoselectivity (see scheme; Ad=adamantyl, Ts=4‐toluenesulfonyl).
肼不再是问题:标题转化是通过芳基氯化物和甲苯磺酸与甲苯磺酸酯的交叉偶联反应生成芳基肼的第一个反应。适当设计的钯催化剂可使该反应在温和条件下快速进行,并具有出色的化学选择性(参见方案; Ad =金刚烷基,Ts = 4-甲苯磺酰基)。
Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
申请人:Mathias Paul John
公开号:US20060035922A1
公开(公告)日:2006-02-16
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof;
and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
[EN] BORON CONTAINING COMPOUNDS AND THEIR USES<br/>[FR] COMPOSÉS CONTENANT DU BORE ET LEURS UTILISATIONS
申请人:5METIS INC
公开号:WO2022040157A1
公开(公告)日:2022-02-24
The present disclosure relates to novel boron-containing compounds and their novel uses, e.g., as active ingredients that have pesticidal activity. The disclosure also relates to agrochemical compositions and their use in agriculture or horticulture for the control or prevention of infestation of plants, plant parts, plant propagation materials, harvested food crops, or seeds by pests, specifically fungi and nematodes. The disclosure further relates to methods for promoting plant performance and/or curatively or preventively controlling phytopathogens, (particularly fungi and nematodes) on or in a plant, plant parts, plant propagation materials, seeds, harvested fruits, or vegetables.
Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors
申请人:Mathias John Paul
公开号:US20090239899A1
公开(公告)日:2009-09-24
A compound of formula (I), or a pharmaceutical acceptable salt and/or solvate (including hydrate) thereof;
and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.